This inventor holds 1 USPTO granted patent. Top assignee: Cilian Ag. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Marco Grenningloh: Innovator in Enzyme Research
Introduction
Marco Grenningloh is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of biotechnology, particularly in enzyme research. His work focuses on the enzyme phospholipase A1 derived from the ciliate Tetrahymena.
Latest Patents
Marco Grenningloh holds a patent for the DNA sequence of the enzyme phospholipase A1 of ciliate Tetrahymena, as well as its applications. The patent details a nucleic acid coding for phospholipase A, specifically highlighting the amino acid sequence SEQ ID No. 7. This innovation has potential implications in various biotechnological applications.
Career Highlights
Marco is associated with Cilian AG, where he continues to advance his research in enzyme technology. His work has positioned him as a key figure in the biotechnology sector, contributing to the understanding and utilization of enzymes in various applications.
Collaborations
He collaborates with esteemed colleagues such as Marcus Hartmann and Arno Tiedtke, enhancing the research output and innovation at Cilian AG.
Conclusion
Marco Grenningloh's contributions to enzyme research exemplify the impact of innovative thinking in biotechnology. His patent on phospholipase A1 showcases the potential for advancements in this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile